comparemela.com

Latest Breaking News On - Researchers scientists awards - Page 16 : comparemela.com

Wiley and CRUI sign four-year transitional agreement to accelerate open access publishing in Italy

 E-Mail February 24, 2021 - Hoboken, N.J. - John Wiley & Sons, Inc. today announced a new four-year open access agreement with the Conference of Italian University Rectors (CRUI) to accelerate open access publishing among a growing list of more than 65 universities across Italy. The read and publish agreement allows members of the Conference access to Wiley s subscription journals and grants researchers at participating Italian institutions the ability to publish accepted articles open access in Wiley s hybrid journals for one annual fee. The structure of this agreement allows for a staggered shift towards OA publishing. Starting this year, thousands of the articles published by CRUI University researchers in Wiley journals will be made open access.

Tobacco exposure in kids, risk of increased blood pressure

More than 87,000 scientific papers on coronavirus since pandemic

Scientists from around the world have published more than 87,000 papers about coronavirus between the start of the COVID-19 pandemic and October 2020, a new analysis shows. Even given the importance of the pandemic, researchers were surprised by the huge number of studies and other papers that scientists produced on the subject in such a short time.

Abundance of iron drives cell death and could inform novel treatments for neuroblastoma

 E-Mail IMAGE: This image shows expression of a specific ferroptosis marker called TfR1 in MYCN-amplified neuroblastoma tissues before and after treatment with auranofin, an FDA-approved drug for rheumatoid arthritis. view more  Credit: VCU Massey Cancer Center Neuroblastoma is a cancer that develops in nerve tissue, most commonly in the glands around the kidneys. The gene MYCN is overexpressed in 20-25% of neuroblastoma, and MYCN-amplified neuroblastoma contributes to a considerable percentage of pediatric cancer-related deaths. Anthony Faber, Ph.D., and a team of researchers at VCU Massey Cancer Center were awarded a grant from the American Cancer Society to study how MYCN and an abundance of iron can drive cancer cell death in neuroblastoma and potentially be targeted with novel treatments. This award is the first part of a potential two-stage grant worth a combined total of $600,000.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.